FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions
← catalyst calendarNCT07749170 · readout ≤ 773 d
Sponsored by Penumbra Inc. (industry) · PEN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
250estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-26 | actual | When the study began enrolling |
| Primary completion | Sep 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Sep 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2026-08-06 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Acute Ischemic Stroke
- Acute Ischemic Stroke (AIS) Related to a Distal Occlusion
Interventions
- Device: Endovascular Thrombectomy
- Other: Medical Management
Primary outcome
what the primary-completion date above is the date OFChange in NIHSS at 24 hours
measured 24 hours
Permalink · PEN's whole pipeline · Catalyst calendar · Every registered study · What changed